Anumana

Decision/Risk Analysis · Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care. Anumana is based in Cambridge, MA and was founded in 2021. It was valued at $580 million at its early-stage round in Mar 2025, the last priced event on record. It has raised $185 million across 3 recorded rounds; the latest was a $95.4 million early-stage round in Mar 2025.

PMV mark · valuation
$580.0M
Oct 2026
Priced at
its early-stage round
Mar 2025
Total raised
$185.3M
Last round
Early Stage VC
Mar 2025

Who backs Anumana?

8 investors
InvestorType
MedTech InnovatorOther
MatrixVenture capital
Mayo ClinicOther
Mayo Clinic Ventures—
Matrix Capital ManagementHedge fund
Boston Scientific—
NTTVC—
nference—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Anumana investors

8 investors are on record for Anumana, including MedTech Innovator, Matrix, Mayo Clinic and Mayo Clinic Ventures. The early-stage round in Mar 2025 drew 4 investors.

Free account
More of Anumana with a free account
  • ·Watch Anumana: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Anumana in decision/risk analysis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View